Ionis Pharmaceuticals, Inc.
US ˙ NasdaqGS ˙ US4622221004

Introduksjon

Denne siden gir en grundig analyse av den kjente historikken for insidernes handelsaktiviteter for Joseph H Wender. Insidere er ledere, direktører eller betydelige investorer i et selskap. Det er ulovlig for insidere å gjøre handler i deres selskaper basert på spesifikke, ikke-offentlig informasjon. Dette betyr ikke at det er ulovlig for dem å gjøre noen handler i deres egne selskaper. Imidlertid må de rapportere alle handler til SEC via et skjema 4. Til tross for disse begrensningene, antyder akademisk forskning at insidere - generelt sett - har en tendens til å overgå markedet i sine egne selskaper.

Gjennomsnittlig handelslønnsomhet

Den gjennomsnittlige handelslønnsomheten er den gjennomsnittlige avkastningen av alle åpne markedskjøp gjort av insideren de siste tre årene. For å beregne dette, undersøker vi hvert eneste åpne marked, uplanlagte kjøp som er gjort av insideren, men dette inkluderer ikke alle handler som ble markert som en del av en 10b5-1 handelsplan. Vi beregner deretter gjennomsnittlig ytelse av disse handlene over 3, 6 og 12 måneder, gjennomsnittlig hver av disse varighetene for å generere en endelig ytelsesmåling for hver handel. Til slutt,

Dersom lønnsomheten for denne interne handelen er "N/A", har enten den interne personen ikke gjort noen åpen-markeds kjøp de siste tre årene, eller så er handlene for nylig til å beregne en pålitelig prestasjonsmåler.

Oppdateringsfrekvens: Daglig

Se listen over de mest lønnsomme insidetraderne.

Selskaper med rapporterte insiderposisjoner

SEC-arkiveringene indikerer at Joseph H Wender har rapporterte beholdninger av handler i følgende selskaper:

Verdipapir Navn Siste rapporterte høydepunkter
US:IONS / Ionis Pharmaceuticals, Inc. Director 108 835
US:OUT / OUTFRONT Media Inc. Director 69 996
Hvordan tolke diagrammene

De følgende diagrammene viser aksjens ytelse etter hver åpen markedstransaksjon som ikke var planlagt, utført av Joseph H Wender. Ikke-planlagte handler er handler som ikke ble gjort som en del av en 10b5-1 handelsplan. Aksjeytelsen er kartlagt som kumulativ prosentendring i aksjekursen. For eksempel, hvis en innsidehandel ble gjort 1. januar 2019, vil diagrammet vise daglig prosentendring for verdipapiret til dagens dato. Dersom aksjeprisen går fra $10 til $15 i løpet av denne tiden, vil den kumulative prosentendringen i aksjeprisen være 50%. En endring i prisen fra $10 til $20 vil være 100%, og en endring i prisen fra $10 til $5 vil være - 50%.

Til syvende og sist er målet vårt å avgjøre hvor tett insidernes handler korrelerer med overavkastninger (positiv eller negativ) i aksjekursen for å se om insidere timer sine handler for å tjene på intern informasjon. Se for deg en situasjon der en insider gjør dette. I denne situasjonen, forventer vi enten (a) positive avkastninger etter kjøp, eller (b) negative avkastninger etter salg. I tilfelle (a) KJØP-diagrammet ville vise en serie av oppadgående kurver, som indikerer positive avkastninger etter hver kjøpstransaksjon. I tilfelle (b) ville SALG-diagrammet vise en serie av nedadgående kurver, som indikerer negative avkastninger etter hver salgstransaksjon.

Imidlertid er dette alene ikke nok til å dra konklusjoner. Hvis, for eksempel, aksjeprisen for selskapet steg jevnt over mange år uten å følge en syklisk trend, ville vi forventet at alle postkjøpsdiagrammer skal ha en stigende trend. På samme måte vil ikke-sykliske nedganger over mange år resultere i nedadgående trend i post-trade diagrammer. Ingen av disse diagrammene ville antyde aktiviteter som insidertrening.

Den sterkeste indikatoren ville vært en situasjon der aksjekursen var ekstremt syklisk, og det var både positive signaler i KJØPSdiagrammet og negative plot i SALGSdiagrammet. Denne situasjonen ville vært sterkt antydende om en insider som timet handler til sin økonomiske fordel.

Internkjøp IONS / Ionis Pharmaceuticals, Inc. - Analyse av kortsiktig fortjeneste

I denne seksjonen analyserer vi lønnsomheten av hvert uplanlagt, åpen-marked internsalg som er gjort i IONS / Ionis Pharmaceuticals, Inc.. Denne analysen hjelper til å forstå om den interne personen regelmessig genererer unormale avkastninger, og er verdt å følge. Denne analysen gjelder ett år etter hver handel, og resultatene er teoretiske.

Følgende tabell viser de mest nylige åpne markedskjøpene som ikke var en del av en handelsplan.

Handelsdato Ticker Innsider Rapporterte
aksjer
Rapportert
pris
Justerte
aksjer
Justert
pris
Kostpris Dager til
maks
Pris ved
maks
Maks
fortjeneste ($)
Maks fortjeneste (%)
Det er ingen kjente uplanlagte handler på det åpne markedet for denne insideren og verdipapirkombinasjonen.

Justert pris er prisen justert for splitt. Justerte aksjer er aksjene justert for splitt.

IONS / Ionis Pharmaceuticals, Inc. Insider Trades
Internhandel IONS / Ionis Pharmaceuticals, Inc. - Analyse av kortsiktig tap

I denne seksjonen analyserer vi unngåelsen av kortsiktig tap for hvert uplanlagt, åpen-marked internsalg som er gjort i IONS / Ionis Pharmaceuticals, Inc.. Et jevnt mønster av tap unngåelse kan antyde at fremtidige salgstransaksjoner kan forutsi nedgang i pris. Denne analysen gjelder ett år etter hver handel, og resultatene er teoretiske.

Følgende tabell viser de mest nylige åpne markedskjøpene som ikke var en del av en handelsplan.

Handelsdato Ticker Innsider Rapporterte
aksjer
Rapportert
pris
Justerte
aksjer
Justert
pris
Kostpris Dager til
min
Pris ved
min
Maks tap
unngått ($)
Maks tap
unngått (%)
2019-03-19 IONS WENDER JOSEPH H 10 000 79,6258 10 000 79,6258 796 258 363 43.2500 −363 758 −45,68
2018-05-11 IONS WENDER JOSEPH H 400 44,0200 400 44,0200 17 608
2018-05-11 IONS WENDER JOSEPH H 6 010 45,7900 6 010 45,7900 275 198
2018-05-11 IONS WENDER JOSEPH H 8 590 45,0300 8 590 45,0300 386 808
2015-03-18 ISIS WENDER JOSEPH H 6 100 70,9480 6 100 70,9480 432 783
2015-03-18 ISIS WENDER JOSEPH H 6 400 71,8443 6 400 71,8443 459 804
2015-03-05 ISIS WENDER JOSEPH H 12 500 71,6139 12 500 71,6139 895 174
2015-03-02 ISIS WENDER JOSEPH H 7 000 65,9693 7 000 65,9693 461 785
2015-02-12 ISIS WENDER JOSEPH H 10 000 62,1460 10 000 62,1460 621 460
2014-02-03 ISIS WENDER JOSEPH H 4 700 48,7825 4 700 48,7825 229 278
2014-01-22 ISIS WENDER JOSEPH H 10 000 50,9803 10 000 50,9803 509 803
2013-12-20 ISIS WENDER JOSEPH H 10 000 40,0125 10 000 40,0125 400 125
2013-12-19 ISIS WENDER JOSEPH H 9 731 39,1340 9 731 39,1340 380 813
2013-11-26 ISIS WENDER JOSEPH H 10 000 36,6336 10 000 36,6336 366 336
2013-06-20 ISIS WENDER JOSEPH H 5 447 20,9300 5 447 20,9300 114 006

Justert pris er prisen justert for splitt. Justerte aksjer er aksjene justert for splitt.

IONS / Ionis Pharmaceuticals, Inc. Insider Trades
Innsidernes handelshistorikk

Tabellen viser den komplette listen over innsidehandler gjort av Joseph H Wender som avslørt til Securies Exchange Comission (SEC).

Fildato Transaksjonsdato Skjema Ticker Verdipapir Kode 10b5-1 Aksjer Gjenværende aksjer Prosent
endring
Aksje
pris
Transaksjons
verdi
Gjenværende
verdi
2025-09-04 2025-09-03 4 IONS IONIS PHARMACEUTICALS INC
Common Stock
S - Sale X −11 200 108 835 −9,33 60,14 −673 549 6 545 152
2025-09-04 2025-09-02 4 IONS IONIS PHARMACEUTICALS INC
Common Stock
S - Sale X −5 600 120 035 −4,46 57,53 −322 174 6 905 746
2025-09-04 2025-09-02 4 IONS IONIS PHARMACEUTICALS INC
Common Stock
S - Sale X −11 200 125 635 −8,19 55,04 −616 432 6 914 775
2025-09-04 2025-09-03 4 IONS IONIS PHARMACEUTICALS INC
Common Stock
S - Sale X −11 200 108 835 −9,33 60,14 −673 549 6 545 152
2025-09-04 2025-09-02 4 IONS IONIS PHARMACEUTICALS INC
Common Stock
S - Sale X −5 600 120 035 −4,46 57,53 −322 174 6 905 746
2025-09-04 2025-09-02 4 IONS IONIS PHARMACEUTICALS INC
Common Stock
S - Sale X −11 200 125 635 −8,19 55,04 −616 432 6 914 775
2025-07-17 2025-07-15 4 IONS IONIS PHARMACEUTICALS INC
Common Stock
M - Exercise 4 079 136 835 3,07
2025-06-05 2025-06-03 4 OUT OUTFRONT Media Inc.
Common Stock
A - Award 771 69 996 1,11
2025-06-05 2025-06-03 4 OUT OUTFRONT Media Inc.
Common Stock
M - Exercise 10 125 69 225 17,13
2024-07-17 2024-07-15 4 IONS IONIS PHARMACEUTICALS INC
Common Stock
M - Exercise 4 677 132 756 3,65
2024-06-10 2024-06-06 4 OUT OUTFRONT Media Inc.
Common Stock
A - Award 624 59 356 1,06
2024-06-10 2024-06-06 4 OUT OUTFRONT Media Inc.
Common Stock
M - Exercise 9 863 58 732 20,18
2024-05-13 2024-05-09 4 IONS IONIS PHARMACEUTICALS INC
Common Stock
M - Exercise 16 000 128 079 14,28 35,53 568 480 4 550 647
2023-07-19 2023-07-17 4 IONS IONIS PHARMACEUTICALS INC
Common Stock
M - Exercise 5 333 112 079 5,00
2023-07-19 2023-07-17 4 IONS IONIS PHARMACEUTICALS INC
Common Stock
M - Exercise 1 777 106 746 1,69
2023-06-08 2023-06-07 4 OUT OUTFRONT Media Inc.
Common Stock
A - Award 576 48 869 1,19
2023-06-08 2023-06-07 4 OUT OUTFRONT Media Inc.
Common Stock
M - Exercise 7 290 48 293 17,78
2022-07-19 2022-07-15 4 IONS IONIS PHARMACEUTICALS INC
Common Stock
M - Exercise 2 665 104 969 2,60
2022-07-19 2022-07-15 4 IONS IONIS PHARMACEUTICALS INC
Common Stock
M - Exercise 5 333 102 304 5,50
2022-06-09 2022-06-08 4 OUT OUTFRONT Media Inc.
Common Stock
A - Award 201 41 003 0,49
2022-06-09 2022-06-08 4 OUT OUTFRONT Media Inc.
Common Stock
M - Exercise 4 907 40 802 13,67
2021-07-19 2021-07-15 4 IONS IONIS PHARMACEUTICALS INC
Restricted Stock Unit
M - Exercise −1 778 9 775 −15,39
2021-07-19 2021-07-15 4 IONS IONIS PHARMACEUTICALS INC
Restricted Stock Unit
M - Exercise −666 11 553 −5,45
2021-07-19 2021-07-15 4 IONS IONIS PHARMACEUTICALS INC
Restricted Stock Unit
M - Exercise −889 12 219 −6,78
2021-07-19 2021-07-15 4 IONS IONIS PHARMACEUTICALS INC
Restricted Stock Unit
M - Exercise −5 333 13 108 −28,92
2021-07-19 2021-07-15 4 IONS IONIS PHARMACEUTICALS INC
Common Stock
M - Exercise 1 778 96 971 1,87
2021-07-19 2021-07-15 4 IONS IONIS PHARMACEUTICALS INC
Common Stock
M - Exercise 666 95 193 0,70
2021-07-19 2021-07-15 4 IONS IONIS PHARMACEUTICALS INC
Common Stock
M - Exercise 889 94 527 0,95
2021-07-19 2021-07-15 4 IONS IONIS PHARMACEUTICALS INC
Common Stock
M - Exercise 5 333 93 638 6,04
2021-07-06 2021-07-01 4 IONS IONIS PHARMACEUTICALS INC
Restricted Stock Unit
A - Award 5 333 18 441 40,69
2021-07-06 2021-07-01 4 IONS IONIS PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
A - Award 12 000 12 000
2021-06-09 2021-06-08 4 OUT OUTFRONT Media Inc.
Restricted Share Units
M - Exercise −6 366 0 −100,00
2021-06-09 2021-06-08 4 OUT OUTFRONT Media Inc.
Restricted Share Units
A - Award 4 907 4 907
2021-06-09 2021-06-08 4 OUT OUTFRONT Media Inc.
Common Stock
M - Exercise 6 366 35 895 21,56
2020-09-18 2020-09-16 4 IONS IONIS PHARMACEUTICALS INC
Director Stock Option (right to buy)
M - Exercise −11 250 0 −100,00
2020-09-18 2020-09-16 4 IONS IONIS PHARMACEUTICALS INC
Director Stock Option (right to buy)
M - Exercise −11 250 0 −100,00
2020-09-18 2020-09-16 4 IONS IONIS PHARMACEUTICALS INC
Common Stock
M - Exercise 11 250 88 305 14,60 28,47 320 288 2 514 043
2020-09-18 2020-09-16 4 IONS IONIS PHARMACEUTICALS INC
Common Stock
M - Exercise 11 250 77 055 17,10 12,94 145 575 997 092
2020-07-06 2020-07-06 4 IONS IONIS PHARMACEUTICALS INC
Restricted Stock Units
M - Exercise −667 666 −50,04
2020-07-06 2020-07-06 4 IONS IONIS PHARMACEUTICALS INC
Common Stock
M - Exercise 667 65 805 1,02
2020-07-06 2020-07-02 4 IONS IONIS PHARMACEUTICALS INC
Restricted Stock Units
M - Exercise −889 1 777 −33,35
2020-07-06 2020-07-02 4 IONS IONIS PHARMACEUTICALS INC
Common Stock
M - Exercise 889 65 138 1,38
2020-07-06 2020-07-01 4 IONS IONIS PHARMACEUTICALS INC
Director Stock Option (right to buy)
A - Award 12 000 12 000
2020-07-06 2020-07-01 4 IONS IONIS PHARMACEUTICALS INC
Restricted Stock Units
A - Award 5 333 5 333
2020-07-06 2020-07-01 4 IONS IONIS PHARMACEUTICALS INC
Restricted Stock Units
M - Exercise −1 778 5 332 −25,01
2020-07-06 2020-07-01 4 IONS IONIS PHARMACEUTICALS INC
Restricted Stock Units
M - Exercise −666 0 −100,00
2020-07-06 2020-07-01 4 IONS IONIS PHARMACEUTICALS INC
Common Stock
M - Exercise 1 778 64 249 2,85
2020-07-06 2020-07-01 4 IONS IONIS PHARMACEUTICALS INC
Common Stock
M - Exercise 666 62 471 1,08
2020-06-10 2020-06-10 4 OUT OUTFRONT Media Inc.
Restricted Share Units
M - Exercise −4 610 0 −100,00
2020-06-10 2020-06-10 4 OUT OUTFRONT Media Inc.
Common Stock
A - Award 312 29 529 1,07
2020-06-10 2020-06-10 4 OUT OUTFRONT Media Inc.
Common Stock
M - Exercise 4 610 29 217 18,73
2020-06-10 2020-06-08 4 OUT OUTFRONT Media Inc.
Restricted Share Units
A - Award 6 366 6 366
2019-07-03 2019-07-03 4 IONS IONIS PHARMACEUTICALS INC
Restricted Stock Units
M - Exercise −667 1 333 −33,35
2019-07-03 2019-07-03 4 IONS IONIS PHARMACEUTICALS INC
Common Stock
M - Exercise 667 61 805 1,09
2019-07-03 2019-07-02 4 IONS IONIS PHARMACEUTICALS INC
Restricted Stock Units
M - Exercise −889 2 666 −25,01
2019-07-03 2019-07-02 4 IONS IONIS PHARMACEUTICALS INC
Common Stock
M - Exercise 889 61 138 1,48
2019-07-03 2019-07-01 4 IONS IONIS PHARMACEUTICALS INC
Director Stock Option (right to buy)
A - Award 16 000 16 000
2019-07-03 2019-07-01 4 IONS IONIS PHARMACEUTICALS INC
Restricted Stock Units
A - Award 7 110 7 110
2019-07-03 2019-07-01 4 IONS IONIS PHARMACEUTICALS INC
Restricted Stock Units
M - Exercise −667 666 −50,04
2019-07-03 2019-07-01 4 IONS IONIS PHARMACEUTICALS INC
Restricted Stock Units
M - Exercise −666 0 −100,00
2019-07-03 2019-07-01 4 IONS IONIS PHARMACEUTICALS INC
Common Stock
M - Exercise 667 60 249 1,12
2019-07-03 2019-07-01 4 IONS IONIS PHARMACEUTICALS INC
Common Stock
M - Exercise 666 59 582 1,13
2019-06-11 2019-06-11 4 OUT OUTFRONT Media Inc.
Restricted Share Units
M - Exercise −6 018 4 610 −56,62
2019-06-11 2019-06-11 4 OUT OUTFRONT Media Inc.
Common Stock
A - Award 254 24 607 1,04
2019-06-11 2019-06-11 4 OUT OUTFRONT Media Inc.
Common Stock
M - Exercise 6 018 24 353 32,82
2019-06-11 2019-06-10 4 OUT OUTFRONT Media Inc.
Restricted Share Units
A - Award 4 610 10 628 76,60
2019-03-20 2019-03-19 4 IONS IONIS PHARMACEUTICALS INC
Common Stock
S - Sale −10 000 58 916 −14,51 79,63 −796 258 4 691 234
2018-07-19 2018-07-17 4 IONS IONIS PHARMACEUTICALS INC
Non-Employee Director Stock Option (right to buy)
M - Exercise −15 000 0 −100,00
2018-07-19 2018-07-17 4 IONS IONIS PHARMACEUTICALS INC
Non-Employee Director Stock Option (right to buy)
M - Exercise −15 000 0 −100,00
2018-07-19 2018-07-17 4 IONS IONIS PHARMACEUTICALS INC
Common Stock
M - Exercise 15 000 68 916 27,82 9,30 139 500 640 919
2018-07-19 2018-07-17 4 IONS IONIS PHARMACEUTICALS INC
Common Stock
M - Exercise 15 000 53 916 38,54 9,22 138 300 497 106
2018-07-03 2018-07-03 4 IONS IONIS PHARMACEUTICALS INC
Restricted Stock Units
M - Exercise −667 2 000 −25,01
2018-07-03 2018-07-03 4 IONS IONIS PHARMACEUTICALS INC
Common Stock
M - Exercise 667 38 916 1,74
2018-07-03 2018-07-02 4 IONS IONIS PHARMACEUTICALS INC
Director Stock Option (right to buy)
A - Award 16 000 16 000
2018-07-03 2018-07-02 4 IONS IONIS PHARMACEUTICALS INC
Restricted Stock Units
A - Award 3 555 3 555
2018-07-03 2018-07-01 4 IONS IONIS PHARMACEUTICALS INC
Restricted Stock Units
M - Exercise −2 000 1 999 −50,01
2018-07-03 2018-07-01 4 IONS IONIS PHARMACEUTICALS INC
Common Stock
M - Exercise 2 000 38 249 5,52
2018-06-14 2018-06-12 4 OUT OUTFRONT Media Inc.
Restricted Share Units
M - Exercise −5 307 0 −100,00
2018-06-14 2018-06-12 4 OUT OUTFRONT Media Inc.
Common Stock
A - Award 286 18 335 1,58
2018-06-14 2018-06-12 4 OUT OUTFRONT Media Inc.
Common Stock
M - Exercise 5 307 18 049 41,65
2018-06-13 2018-06-11 4 OUT OUTFRONT Media Inc.
Restricted Share Units
A - Award 6 018 6 018
2018-05-11 2018-05-11 4 IONS IONIS PHARMACEUTICALS INC
Director Stock Option (right to buy)
M - Exercise −15 000 0 −100,00
2018-05-11 2018-05-11 4 IONS IONIS PHARMACEUTICALS INC
Common Stock
S - Sale −8 590 36 249 −19,16 45,03 −386 808 1 632 292
2018-05-11 2018-05-11 4 IONS IONIS PHARMACEUTICALS INC
Common Stock
M - Exercise 8 590 44 839 23,70 13,88 119 229 622 365
2018-05-11 2018-05-11 4 IONS IONIS PHARMACEUTICALS INC
Common Stock
S - Sale −6 010 36 249 −14,22 45,79 −275 198 1 659 842
2018-05-11 2018-05-11 4 IONS IONIS PHARMACEUTICALS INC
Common Stock
M - Exercise 6 010 42 259 16,58 13,88 83 419 586 555
2018-05-11 2018-05-11 4 IONS IONIS PHARMACEUTICALS INC
Common Stock
S - Sale −400 36 249 −1,09 44,02 −17 608 1 595 681
2018-05-11 2018-05-11 4 IONS IONIS PHARMACEUTICALS INC
Common Stock
M - Exercise 400 36 649 1,10 13,88 5 552 508 688
2017-07-03 2017-07-03 4 IONS IONIS PHARMACEUTICALS INC
Director Stock Option (right to buy)
A - Award 16 000 16 000
2017-07-03 2017-07-03 4 IONS IONIS PHARMACEUTICALS INC
Restricted Stock Units
A - Award 2 667 2 667
2017-07-03 2017-07-01 4 IONS IONIS PHARMACEUTICALS INC
Restricted Stock Units
M - Exercise −2 469 3 999 −38,17
2017-07-03 2017-07-01 4 IONS IONIS PHARMACEUTICALS INC
Common Stock
M - Exercise 2 469 36 249 7,31
2017-06-14 2017-06-12 4 OUT OUTFRONT Media Inc.
Restricted Share Units
A - Award 5 307 5 307
2017-06-09 2017-06-07 4 OUT OUTFRONT Media Inc.
Restricted Share Units
M - Exercise −5 183 0 −100,00
2017-06-09 2017-06-07 4 OUT OUTFRONT Media Inc.
Common Stock
A - Award 319 12 742 2,57
2017-06-09 2017-06-07 4 OUT OUTFRONT Media Inc.
Common Stock
M - Exercise 5 183 12 423 71,59
2016-07-06 2016-07-02 4 IONS IONIS PHARMACEUTICALS INC
Restricted Stock Units
M - Exercise −312 0 −100,00
2016-07-06 2016-07-02 4 IONS IONIS PHARMACEUTICALS INC
Common Stock
M - Exercise 312 33 780 0,93
2016-07-06 2016-07-01 4 IONS IONIS PHARMACEUTICALS INC
Director Stock Option (right to buy)
A - Award 16 000 16 000
2016-07-06 2016-07-01 4 IONS IONIS PHARMACEUTICALS INC
Restricted Stock Units
A - Award 2 667 2 667
2016-07-06 2016-07-01 4 IONS IONIS PHARMACEUTICALS INC
Restricted Stock Units
M - Exercise −1 803 3 801 −32,17
2016-07-06 2016-07-01 4 IONS IONIS PHARMACEUTICALS INC
Common Stock
M - Exercise 469 33 468 1,42
2016-07-06 2016-07-01 4 IONS IONIS PHARMACEUTICALS INC
Common Stock
M - Exercise 667 32 999 2,06
2016-07-06 2016-07-01 4 IONS IONIS PHARMACEUTICALS INC
Common Stock
M - Exercise 667 32 999 2,06
2016-06-13 2016-06-09 4 OUT OUTFRONT Media Inc.
Restricted Share Units
M - Exercise −4 461 0 −100,00
2016-06-13 2016-06-09 4 OUT OUTFRONT Media Inc.
Common Stock
A - Award 262 7 240 3,75
2016-06-13 2016-06-09 4 OUT OUTFRONT Media Inc.
Common Stock
M - Exercise 4 461 6 978 177,23
2016-06-09 2016-06-07 4 OUT OUTFRONT Media Inc.
Restricted Share Units
A - Award 5 183 5 183
2015-07-02 2015-07-02 4 ISIS ISIS PHARMACEUTICALS INC
Restricted Stock Units
M - Exercise −312 312 −50,00
2015-07-02 2015-07-02 4 ISIS ISIS PHARMACEUTICALS INC
Common Stock
M - Exercise 312 31 665 1,00
2015-07-02 2015-07-01 4 ISIS ISIS PHARMACEUTICALS INC
Director Stock Option (right to buy)
A - Award 16 000 16 000
2015-07-02 2015-07-01 4 ISIS ISIS PHARMACEUTICALS INC
Restricted Stock Units
A - Award 2 667 2 667
2015-07-02 2015-07-01 4 ISIS ISIS PHARMACEUTICALS INC
Restricted Stock Units
M - Exercise −667 2 000 −25,01
2015-07-02 2015-07-01 4 ISIS ISIS PHARMACEUTICALS INC
Restricted Stock Units
M - Exercise −469 937 −33,36
2015-07-02 2015-07-01 4 ISIS ISIS PHARMACEUTICALS INC
Common Stock
M - Exercise 667 31 353 2,17
2015-07-02 2015-07-01 4 ISIS ISIS PHARMACEUTICALS INC
Common Stock
M - Exercise 469 30 686 1,55
2015-06-11 2015-06-09 4 OUT OUTFRONT Media Inc.
Restricted Share Units
A - Award 4 461 4 461
2015-04-03 2015-03-28 4/A OUT OUTFRONT Media Inc.
Common Stock
M - Exercise 2 438 2 517 3 086,08
2015-03-31 2015-03-28 4 OUT OUTFRONT Media Inc.
Restricted Share Units
M - Exercise −2 438 0 −100,00
2015-03-31 2015-03-28 4 OUT OUTFRONT Media Inc.
Common Stock
F - Taxes −913 1 604 −36,27 30,09 −27 472 48 264
2015-03-31 2015-03-28 4 OUT OUTFRONT Media Inc.
Common Stock
M - Exercise 2 438 2 517 3 086,08
2015-03-20 2015-03-18 4 ISIS ISIS PHARMACEUTICALS INC
Director Stock Option (right to buy)
M - Exercise −12 500 0 −100,00
2015-03-20 2015-03-18 4 ISIS ISIS PHARMACEUTICALS INC
Common Stock
S - Sale −6 400 30 217 −17,48 71,84 −459 804 2 170 919
2015-03-20 2015-03-18 4 ISIS ISIS PHARMACEUTICALS INC
Common Stock
M - Exercise 6 400 36 617 21,18 5,93 37 952 217 139
2015-03-20 2015-03-18 4 ISIS ISIS PHARMACEUTICALS INC
Common Stock
S - Sale −6 100 30 217 −16,80 70,95 −432 783 2 143 836
2015-03-20 2015-03-18 4 ISIS ISIS PHARMACEUTICALS INC
Common Stock
M - Exercise 6 100 36 317 20,19 5,93 36 173 215 360
2015-03-09 2015-03-05 4 ISIS ISIS PHARMACEUTICALS INC
Director Stock Option (right to buy)
M - Exercise −12 500 0 −100,00
2015-03-09 2015-03-05 4 ISIS ISIS PHARMACEUTICALS INC
Common Stock
S - Sale −12 500 30 217 −29,26 71,61 −895 174 2 163 957
2015-03-09 2015-03-05 4 ISIS ISIS PHARMACEUTICALS INC
Common Stock
M - Exercise 12 500 42 717 41,37 9,77 122 125 417 345
2015-03-04 2015-03-02 4 ISIS ISIS PHARMACEUTICALS INC
Common Stock
S - Sale −7 000 30 217 −18,81 65,97 −461 785 1 993 394
2015-02-17 2015-02-12 4 ISIS ISIS PHARMACEUTICALS INC
Non-Employee Director Stock Option (right to buy)
M - Exercise −10 000 0 −100,00
2015-02-17 2015-02-12 4 ISIS ISIS PHARMACEUTICALS INC
Common Stock
S - Sale −10 000 37 217 −21,18 62,15 −621 460 2 312 888
2015-02-17 2015-02-12 4 ISIS ISIS PHARMACEUTICALS INC
Common Stock
M - Exercise 10 000 47 217 26,87 3,95 39 500 186 507
2014-07-02 2014-07-02 4 ISIS ISIS PHARMACEUTICALS INC
Restricted Stock Units
M - Exercise −313 624 −33,40
2014-07-02 2014-07-02 4 ISIS ISIS PHARMACEUTICALS INC
Common Stock
M - Exercise 313 37 217 0,85
2014-07-02 2014-07-01 4 ISIS ISIS PHARMACEUTICALS INC
Director Stock Option (right to buy)
A - Award 16 000 16 000
2014-07-02 2014-07-01 4 ISIS ISIS PHARMACEUTICALS INC
Restricted Stock Units
A - Award 2 667 2 667
2014-07-02 2014-07-01 4 ISIS ISIS PHARMACEUTICALS INC
Restricted Stock Units
M - Exercise −469 1 406 −25,01
2014-07-02 2014-07-01 4 ISIS ISIS PHARMACEUTICALS INC
Common Stock
M - Exercise 469 36 904 1,29
2014-04-01 2014-03-28 4 CBSO CBS OUTDOOR AMERICAS INC.
Restricted Share Units
A - Award 2 143 2 143
2014-02-07 2014-02-06 4 ISIS ISIS PHARMACEUTICALS INC
Director Stock Option (right to buy)
M - Exercise −5 300 0 −100,00
2014-02-07 2014-02-06 4 ISIS ISIS PHARMACEUTICALS INC
Common Stock
M - Exercise 5 300 36 435 17,02 5,72 30 316 208 408
2014-02-05 2014-02-03 4 ISIS ISIS PHARMACEUTICALS INC
Director Stock Option (right to buy)
M - Exercise −4 700 5 300 −47,00
2014-02-05 2014-02-03 4 ISIS ISIS PHARMACEUTICALS INC
Common Stock
S - Sale −4 700 31 135 −13,12 48,78 −229 278 1 518 843
2014-02-05 2014-02-03 4 ISIS ISIS PHARMACEUTICALS INC
Common Stock
M - Exercise 4 700 35 835 15,10 5,72 26 884 204 976
2014-01-24 2014-01-22 4 ISIS ISIS PHARMACEUTICALS INC
Common Stock
S - Sale −10 000 31 135 −24,31 50,98 −509 803 1 587 272
2013-12-20 2013-12-20 4 ISIS ISIS PHARMACEUTICALS INC
Common Stock
S - Sale −10 000 41 135 −19,56 40,01 −400 125 1 645 914
2013-12-20 2013-12-19 4 ISIS ISIS PHARMACEUTICALS INC
Director Stock Option (right to buy)
M - Exercise −15 000 0 −100,00
2013-12-20 2013-12-19 4 ISIS ISIS PHARMACEUTICALS INC
Common Stock
S - Sale −9 731 51 135 −15,99 39,13 −380 813 2 001 117
2013-12-20 2013-12-19 4 ISIS ISIS PHARMACEUTICALS INC
Common Stock
M - Exercise 15 000 60 866 32,70 16,32 244 800 993 333
2013-11-27 2013-11-26 4 ISIS ISIS PHARMACEUTICALS INC
Common Stock
S - Sale −10 000 45 866 −17,90 36,63 −366 336 1 680 237
2013-07-03 2013-07-02 4 ISIS ISIS PHARMACEUTICALS INC
Restricted Stock Units
M - Exercise −313 937 −25,04
2013-07-03 2013-07-02 4 ISIS ISIS PHARMACEUTICALS INC
Common Stock
M - Exercise 313 55 866 0,56
2013-07-03 2013-07-01 4 ISIS ISIS PHARMACEUTICALS INC
Restricted Stock Units
A - Award 1 875 1 875
2013-07-03 2013-07-01 4 ISIS ISIS PHARMACEUTICALS INC
Director Stock Option (right to buy)
A - Award 11 250 11 250
2013-06-24 2013-06-20 4 ISIS ISIS PHARMACEUTICALS INC
Director Stock Option (right to buy)
M - Exercise −10 000 0 −100,00
2013-06-24 2013-06-20 4 ISIS ISIS PHARMACEUTICALS INC
Common stock
S - Sale −5 447 55 553 −8,93 20,93 −114 006 1 162 724
2013-06-24 2013-06-20 4 ISIS ISIS PHARMACEUTICALS INC
Common Stock
M - Exercise 10 000 61 000 19,61 5,17 51 700 315 370
2012-07-03 2012-07-02 4 ISIS ISIS PHARMACEUTICALS INC
Director Stock Option (right to buy)
A - Award 11 250 11 250
2012-07-03 2012-07-02 4 ISIS ISIS PHARMACEUTICALS INC
Restricted Stock Units
A - Award 1 250 1 250
2012-06-13 2012-06-12 4 ISIS ISIS PHARMACEUTICALS INC
Director Stock Option (right to buy)
M - Exercise −10 000 0 −100,00
2012-06-13 2012-06-12 4 ISIS ISIS PHARMACEUTICALS INC
Common Stock
M - Exercise 10 000 51 000 24,39 8,15 81 500 415 650
2005-07-06 2005-07-01 4 ISIS ISIS PHARMACEUTICALS INC
Director Stock Option (right to buy)
A - Award 10 000 10 000
2004-07-02 2004-07-01 4 ISIS ISIS PHARMACEUTICALS INC
Director Stock Option (right to buy)
A - Award 10 000 10 000
P
Åpent marked eller private kjøp av ikke-derivat eller derivat sikkerhet.
S
Åpent marked eller private kjøp av ikke-derivat eller derivat sikkerhet.
A
Bevilgning, tildeling eller andre oppkjøp av verdipapirer fra selskapet (slik som en opsjon)
C
Konvertering av derivat
D
Salg eller overføring av verdipapirer tilbake til selskapet
F
Betaling av utøvelseskurs eller skatteplikt ved å bruke deler av verdipapirer mottat fra selskapet
G
Gave av verdipapirer fra eller til insidere
K
Aksjebytting og lignende sikringsavtaler
M
Øvelse eller konvertering av derivatverdipapir mottatt fra selskapet (for eksempel en opsjon)
V
En transaksjon frivilig rapportert på Skjema 4
J
Annet (med en fotnote som beskriver transaksjonen)